Остеоартроз-2013 – новые направления в лечении


Н.А. Шостак

В статье приводятся современные представления о патогенезе остеоартроза, главные подходы к диагностике заболевания. Освещены основные проблемы в лечении заболевания, приводятся данные по эффективности и безопасности использования стронция ранелата при остеоартрозе.

Литература


1. Zhang W, Moskowitz RW, Nuki G, et al. OARSI recommendations for the management of hip and knee osteoarthritis, part I: critical appraisal of existing treatment guidelines and systematic review of current research evidence. Osteoarthritis Cartilage 2007;15(9):981–1000.
2. Zhang W, Moskowitz RW, Nuki G, et al. OARSI recommendations for the management of hip and knee osteoarthritis, Part II: OARSI evidence-based, expert consensus guidelines. Osteoarthritis Cartilage 2008;16(2):137–62.
3. Altman R, Asch E, Bloch D, et al. Development of criteria for the classification and reporting of osteoarthritis. Classification of osteoarthritis of the knee. Arthritis Rheum1986;29(8):1039–49.
4. Клинические рекомендации. Ревматология/Под ред. Е.Л. Насонова. М., 2006.
5. Sowers MR, McConnell D, Jannausch M, et al. Estradiol and its metabolites and their association
with knee osteoarthritis. Arthritis Rheum 2006;54(8):2481–87.
6. Davis MA, Ettinger WH, Neuhaus JM, Mallon KP. Knee osteoarthritis and physical functioning: evidence
from the NHANES I Epidemiologic FollowupStudy. J Rheumatol 1991;18:591–98.
7. Riyazi N, Meulenbelt I, Kroon HM, et al. Evidence for familial aggregation of hand, Hip, and spine
but not knee osteoarthritis in siblings with multiple joint involvement: the GARP study. Ann
Rheum Dis 2005;64:438–43.
8. Holmberg S, Thelin A, Thelin N. Knee osteoarthritis and body mass index: a populationbased case-control study. Scand J Rheumatol 2005;34(1):59–64.
9. Jancin B. Randomized Trial: Weight Loss Benefits Knee OA. Rheumatology News 2005;4(9):1–2.
10. Goldriring MB. The role of the chondrocyte in osteoarthritis. Arthritis Rheum 2000;43(9):1916–26.
11. Monfort J, Garcia-Giralt N, Lopez-Armada MJ, et al. Decreased metalloproteinase production as a response to mechanical pressure in human cartilage: a mechanism for homeostatic regulation.
Arthritis Res Ther 2006;8(5):149.
12. Алексеева Л.И., Зайцева Е.М. Субхондральная кость при остеоартрозе: новые возможности терапии // РМЖ 2004. № 12. С. 1133–36.
13. Webb GR, Westacott CI, Elson CJ. Osteoarthritic synovial fluid and synovium supernatants upregulate
tumor necrosis factor receptors on human articular chondrocytes. Osteoarthritis Cartilage 1998;6(3):167–76.
14. Li B, Marshall D, Roe M, Aspden RM. The electron microscope appearance of the subchondral
bone plate in the human femoral head in osteoarthritis and osteoporosis. J Anat 1999;195 (Pt 1):101–10.
15. Karvonen RL, Miller PR, Nelson DA, et al. Periarticular osteoporosis in osteoarthritis of the knee. J Rheumatol 1998;25(11):2187–94.
16. Felson DT, McLaughlin S, Goggins J, et al. Bone marrow edema and its relation to progression of knee osteoarthritis. Ann Intern Med 2003;139:330–36.
17. Tanamas SK, Wluka AE, Pelletier JP, et al. The association between subchondral bone cysts and
tibial cartilage volume and risk of joint replacementin people with knee osteoarthritis: a longitudinal
study. Arthritis Res Ther 2010;12(2):58.
18. Зайцева Е.М., Алексеева Л.И., Смирнов А.В. Причины боли при остеоартрозе и факторы прогрессирования заболевания (обзор литературы) // Научно-практическая ревматология 2011. № 1. С. 50–7.
19. Zhang W, Doherty M, Peat G, et al. EULAR evidence-based recommendations for the diagnosis of knee osteoarthritis. Ann Rheum Dis 2010;69(3):483–89.
20. Blain H, Chavassieux P, Portero-Muzy N, et al. Cortical and trabecular bone distribution in the femoral neck in osteoporosis and osteoarthritis. Bone 2008;43(5):862–68.
21. Bruyere O, Delferriere D, Roux C, et al. Effects of strontium ranelate on spinal osteoarthritis progression.
Ann Rheum Dis 2008;67:3 335–39.
22. Catalin CF, Dan P, Razvan1 Е, et al. Strontium ranelate may improve mild forms of osteoarthritis
in postmenopausal women with osteoporosis. In: Abstracts of the IOF-ECCEO12 European Congress on Osteoporosis and Osteoarthritis, March 21–24, 2012 and the 2nd IOF-ESCEO Pre-clinical Symposium, March
23–24, 2012, Bordeaux, France. Osteoporos Int 2012;23:(Suppl. 2):25–435.
23. Alexandersen P, Karsdal MA, Qvist P, et al. Strontium ranelate reduces the urinary level of cartilage degradation biomarker CTX-II in postmenopausal women. Bone 2007;40:218–22.
24. Chavassieux P, Brixen K, Zerbini C, et al. Osteoporos Int 2011;22(Suppl.1):S104 (Abstract OC16).


Похожие статьи


Бионика Медиа